Related Experiment Video
Updated: Jun 13, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Sentinel lymph node biopsy and melanoma: 2010 update Part I
William G Stebbins1, Lilit Garibyan, Arthur J Sober
1Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. bstebbins@gmail.com
Journal of the American Academy of Dermatology
|April 20, 2010
Summary
Sentinel lymph node biopsy (SLNB) aids melanoma staging by identifying metastatic cells in regional lymph nodes. While valuable for prognostication, its therapeutic role after positive findings remains debated.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Sentinel lymph node biopsy (SLNB) is a minimally invasive technique for staging regional lymph nodes in early-stage melanoma.
- SLNB improves prognostication accuracy and aids in risk stratification for clinical trials.
Purpose of the Study:
- To review the history and evolution of SLNB for melanoma.
- To discuss updates in surgical techniques, histopathologic evaluation, and cost-effectiveness.
Main Methods:
- Review of historical data and large clinical trials.
- Analysis of current surgical and histopathologic advancements.
- Evaluation of cost-effectiveness.
Main Results:
- SLNB is established for staging and prognostication in melanoma.
- Controversy persists regarding the therapeutic implications of positive sentinel nodes.
Conclusions:
- SLNB is a critical tool in melanoma management.
- Further research is needed to clarify the therapeutic role of complete lymph node dissection following positive SLNB.
